SGLT2 inhibitor administration to two patients with diabetes mellitus with ascites due to cirrhosis

SGLT2 inhibitor administration to two patients with diabetes mellitus with ascites due to cirrhosis

We used the sodium-glucose cotransporter 2 inhibitor, luseogliflozin in two patients with diabetes mellitus with Child–Pugh classification B cirrhosis and cirrhotic ascites. In each case, luseogliflozin was safely used for over three years and was also considered effective in reducing ascites. In on...

Full description

Saved in:
Bibliographic Details
Main Authors: Koji Nagayama, Risako Harada, Hiroshi Ajima, Sakurako Orikasa, Misaki Aoshima, Yutaka Oki
Format: Article
Language:English
Published: Bioscientifica 2025-07-01
Series:Endocrinology, Diabetes & Metabolism Case Reports
Subjects:
cirrhosis
ascites
diabetes mellitus
sodium-glucose cotransporter 2 inhibitor
Online Access:https://edm.bioscientifica.com/view/journals/edm/2025/3/EDM-25-0015.xml
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items